Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

VR Interventions to Reduce the Prevalence of Delirium in ICU Patients

NCT: NCT05525702 · RECRUITING

NCT IDNCT05525702
StatusRECRUITING
Start Date2023-12-18
Completion2026-12-31

Brief Summary

The goal of this clinical trial is to learn the effect of Virtual Reality Family Support System (VRFS) on reducing delirium in ICU mechanically ventilated patients. The main question it aims to answer is: ·Using VRFS for participant intervention, can it reduce the incidence of delirium and improve clinical outcomes? Researchers will investigate whether the implementation of VRFS can reduce the number of delirium days and improve clinical outcomes. Participants will: * Receive the VRFS intervention until the endotracheal tube (ETT) is removed. * Have physiological data collected, including EEG, oxygen saturation levels, ECG, and blood pressure. * Keep a diary of delirium, dosage of sedative and analgesic drugs, the duration of mechanical ventilation, and ICU stays.

Frequently Asked Questions

What is VR Interventions to Reduce the Prevalence of Delirium in ICU Patients?

VR Interventions to Reduce the Prevalence of Delirium in ICU Patients is a clinical trial registered under NCT05525702. Current status: RECRUITING.

What is the status of NCT05525702?

The current status of NCT05525702 (VR Interventions to Reduce the Prevalence of Delirium in ICU Patients) is: RECRUITING.

When did VR Interventions to Reduce the Prevalence of Delirium in ICU Patients start?

VR Interventions to Reduce the Prevalence of Delirium in ICU Patients started on 2023-12-18.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.